Alternatives to Foresee Genomics
Foresee Genomics is a Healthcare tool: personalized diagnostics for cancer genomic markers at the point of treatment. Here are the 43 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Healthcare companies to Foresee Genomics
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
ImmunaiNot ratedMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Nucleai3.0 out of 5 (1)AI-powered spatial biology platform for precision medicine and drug development.
VariantyxNot ratedVariantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.
ImageneNot ratedAI-powered platform for profiling cancer biomarkers from digitized biopsy images.
FORE BiotherapeuticsNot ratedPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
NucleixNot ratedNucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
Pangea BiomedNot ratedBiotech company using AI and deep RNA analysis to predict cancer treatment response.
OncohostNot ratedLeveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.
SenseeraNot ratedDeveloping a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.
CytoReasonNot ratedDevelops a computational model of the human body for drug discovery and development.
C2i GenomicsNot ratedComprehensive whole-genome monitoring for cancer recurrence and progression.
Genoox3.0 out of 5 (1)Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.
UkkoNot ratedUkko is developing novel food allergy and disorder treatments using advanced immunology and plant science.
MeMedNot ratedMeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
Insitro3.0 out of 5 (1)Data-driven drug discovery and development company using machine learning and high-throughput biology.
Early LabsNot ratedPioneering volatile markers (VM) tests for early cancer detection in large-scale populations.
Biolojic DesignNot ratedDevelops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.
SpotitEarlyNot ratedScent-based multi-cancer early detection screening test using AI and bio-detectors.
InfiniplexNot ratedInfiniplex offers a comprehensive cancer screening platform utilizing advanced AI and multi-omic analysis.
Showing the next 20 closest matches. See the rest on the Foresee Genomics profile.
Sponsored rows are paid and labelled. Advertise on this page

